SUBACUTE PULMONARY FAILURE COMPLICATING THERAPY WITH HIGH-DOSE ARA-C IN ACUTE-LEUKEMIA

被引：0
|
作者：
ANDERSSON, BS [1 ]
COGAN, BM [1 ]
KEATING, MJ [1 ]
ESTEY, EH [1 ]
MCCREDIE, KB [1 ]
FREIREICH, EJ [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT RADIOL,HOUSTON,TX 77030
来源：
CANCER | 1985年 / 56卷 / 09期
关键词：
D O I：
10.1002/1097-0142(19851101)56:9<2181::AID-CNCR2820560907>3.0.CO;2-B
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2181 / 2184
页数：4
相关论文
共 50 条
  • [41] Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia.
    Link, H
    Ehninger, G
    SchonrockNabulsi
    Gramatzki
    Franke, A
    Einsele, H
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gackle, R
    Ohl, S
    Heidemann, E
    Wilhelm, M
    Loffler, B
    Weiss, J
    Geer, T
    Diehl, S
    Wandt, H
    BLOOD, 1996, 88 (10) : 2723 - 2723
  • [42] SATURATION OF ARA-CTP ACCUMULATION DURING HIGH-DOSE ARA-C THERAPY - PHARMACOLOGICAL RATIONALE FOR INTERMEDIATE-DOSE ARA-C
    PLUNKETT, W
    LILIEMARK, JO
    ESTEY, E
    KEATING, MJ
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 159 - 166
  • [43] NEUROTOXICITY OF COMBINATION THERAPY WITH HIGH-DOSAGE ARA-C AND MITOXANTRONE IN 35 PATIENTS WITH ACUTE-LEUKEMIA
    KREUTZMANN, H
    HIDDEMANN, W
    MASCHMEYER, G
    WENDT, F
    BLUT, 1986, 53 (03): : 242 - 242
  • [44] High dose ara-C as upfront therapy for adult patients with acute lymphoblastic leukemia (ALL).
    Hallbook, H
    Simonsson, B
    Bjorkholm, M
    Braide, I
    Carneskog, J
    Grimfors, G
    Hast, R
    Karlsson, R
    Kimby, E
    Lerner, R
    Linder, O
    Linderholm, M
    Lofvenberg, E
    Malm, PG
    Nilsson, PG
    Paul, C
    Petrescu, A
    Rodjer, S
    Tidefelt, U
    Turesson, I
    Uden-Blohme, AM
    Vilen, L
    Winquist, I
    Zettervall, O
    Smedmyr, B
    BLOOD, 1999, 94 (10) : 297A - 297A
  • [45] HIGH-DOSE ARA-C PLUS VM-26 IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
    LARSON, RA
    GAYNOR, ER
    SHEPARD, KV
    DALY, KM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (10): : 1261 - 1263
  • [46] A PHASE-II TRIAL OF HIGH-DOSE ARA-C AND MITOXANTRONE IN ACUTE NONLYMPHOBLASTIC LEUKEMIA (ANLL)
    FUHR, HG
    LINDEMANN, A
    HERRMANN, F
    HIDDEMANN, W
    MERTELSMANN, R
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 121 - 121
  • [47] THE PHARMACOLOGIC BASIS FOR THE EFFICACY OF HIGH-DOSE ARA-C AND SEQUENTIAL ASPARAGINASE IN ADULT ACUTE MYELOGENOUS LEUKEMIA
    CAPIZZI, RL
    WHITE, C
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1988, 61 (01): : 11 - 22
  • [48] Curative chemotherapy for acute myeloid leukemia: The development of high-dose ara-C from the laboratory to bedside
    Capizzi, RL
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (03) : 249 - 256
  • [49] Allogeneic bone marrow transplantation compared with high-dose ARA-C post-remission therapy for acute myeloid leukemia
    Link, H
    Ehninger, G
    Hübner, G
    Soucek, S
    Schönrock-Nabulsi, P
    Gramatzki, M
    Franke, A
    Einsele, H
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gäckle, R
    Öhl, S
    Heidemann, E
    Gieseler, F
    Löffler, B
    Weiss, J
    Geer, T
    Wandt, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S13 - S13
  • [50] CLINICAL-TRIAL OF LOW-DOSE ARA-C IN THE TREATMENT OF ACUTE-LEUKEMIA AND MYELODYSPLASIA
    JEHN, U
    DEBOCK, R
    HAANEN, C
    BLUT, 1984, 48 (05): : 255 - 261
12345